Circulating tumor cells and drug history in primary breast cancer patients.

Jurisova, Silvia; Karaba, Marián; Minarik, Gabriel; Benca, Juraj; Sedlackova, Tatiana; Manasova, Daniela; Kalavska, Katarina; Pindak, Daniel; Mardiak, Jozef; Mego, Michal

Jurisova, Silvia; Karaba, Marián; Minarik, Gabriel; Benca, Juraj; Sedlackova, Tatiana; Manasova, Daniela; Kalavska, Katarina; Pindak, Daniel; Mardiak, Jozef; Mego, Michal.

Affiliation

Jurisova S; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava 83310, Slovakia.
Karaba M; National Cancer Institute, Bratislava 83310, Slovakia.
Minarik G; National Cancer Institute, Bratislava 83310, Slovakia.
Benca J; Slovak Medical University, Bratislava 83101, Slovakia.
Sedlackova T; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava 83172, Slovakia.
Manasova D; National Cancer Institute, Bratislava 83310, Slovakia.
Kalavska K; Department of Medicine, St. Elizabeth University, Bratislava 81250, Slovakia.
Pindak D; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava 83172, Slovakia.
Mardiak J; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava 83310, Slovakia.
Mego M; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava 83310, Slovakia.

Cancer Drug Resist ; 3(1): 98-109, 2020.

Article de En | MEDLINE | ID: mdl-35582045

Mots clés

Circulating tumor cells; chronic medication; early breast cancer; epithelial-to-mesenchymal transition

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Cancer Drug Resist Année: 2020 Type de document: Article Pays d'affiliation: Slovaquie Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google